Table 2 AVF characteristics by cannulation technique
| Â | Total | BHs | BHb | RL | AP | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent (%) | Number | Percent (%) of used tech. | Percent (%) of the total | Number | Percent (%) of used tech. | Percent (%) of the total | Number | Percent (%) of used tech. | Percent (%) of the total | Number | Percent (%) of used tech. | Percent (%) of the total | |
Causes of ESRD | ||||||||||||||
 Diabetic nephropathy | 327 | 24.6 | 181 | 24.7 | 55.4 | 101 | 26.3 | 30.9 | 31 | 18.6 | 9.5 | 14 | 31.8 | 4.3 |
 Hypertension | 221 | 16.6 | 115 | 15.7 | 52.0 | 68 | 17.7 | 30.8 | 30 | 18.0 | 13.6 | 8 | 18.2 | 3.6 |
Other renal disease | 266 | 20.0 | 149 | 20.3 | 56.0 | 68 | 17.7 | 25.6 | 39 | 23.4 | 14.7 | 10 | 22.7 | 3.8 |
 Unknown diagnosis | 145 | 10.9 | 80 | 10.9 | 55.2 | 36 | 9.4 | 24.8 | 24 | 14.4 | 16.6 | 5 | 11.4 | 3.4 |
 Glomerulonephritis | 187 | 14.1 | 105 | 14.3 | 56.1 | 56 | 14.6 | 29.9 | 22 | 13.2 | 11.8 | 4 | 9.1 | 2.1 |
 Polycystic kidney diseases | 114 | 8.6 | 62 | 8.5 | 54.4 | 36 | 9.4 | 31.6 | 14 | 8.4 | 12.3 | 2 | 4.5 | 1.8 |
 Pyelonephritis | 58 | 4.4 | 35 | 4.8 | 60.3 | 17 | 4.4 | 29.3 | 5 | 3.0 | 8.6 | 1 | 2.3 | 1.7 |
 Renal vascular diseases | 10 | 0.8 | 6 | 0.8 | 60.0 | 2 | 0.5 | 20.0 | 2 | 1.2 | 20.0 | 0 | 0.0 | 0.0 |
AVF type | ||||||||||||||
 Brachiocephal | 356 | 26.8 | 200 | 27.3 | 56.2 | 81 | 21.1 | 22.8 | 67 | 40.1 | 18.8 | 8.0 | 18.2 | 2.2 |
 Proximal radiocephal | 12 | 0.9 | 6 | 0.8 | 50.0 | 5 | 1.3 | 41.7 | 0 | 0.0 | 0.0 | 1.0 | 2.3 | 8.3 |
 Radiobasilica | 5 | 0.4 | 3 | 0.4 | 60.0 | 2 | 0.5 | 40.0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
 Radiocephal | 841 | 63.3 | 459 | 62.6 | 54.6 | 278 | 72.4 | 33.1 | 74 | 44.3 | 8.8 | 30.0 | 68.2 | 3.6 |
 Ulnar | 8 | 0.6 | 4 | 0.5 | 50.0 | 2 | 0.5 | 25.0 | 2 | 1.2 | 25.0 | 0.0 | 0.0 | 0.0 |
 Other | 20 | 1.5 | 8 | 1.1 | 40.0 | 4 | 1.0 | 20.0 | 8 | 4.8 | 40.0 | 0.0 | 0.0 | 0.0 |
 Brachiobasilica transposed 1 stage | 61 | 4.6 | 42 | 5.7 | 68.9 | 3 | 0.8 | 4.9 | 12 | 7.2 | 19.7 | 4.0 | 9.1 | 6.6 |
 Brachiobasilica transposed 2 stage | 20 | 1.5 | 9 | 1.2 | 45.0 | 8 | 2.1 | 40.0 | 2 | 1.2 | 10.0 | 1.0 | 2.3 | 5.0 |
 Thigh. from A. femoralis | 3 | 0.2 | 0 | 0.0 | 0.0 | 1 | 0.3 | 33.3 | 2 | 1.2 | 66.7 | 0.0 | 0.0 | 0.0 |
 Brachiobasilica forearm | 2 | 0.2 | 2 | 0.3 | 100.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
AVF right/left hand side | 369/956 | 28/72 | 204/529 | 28/72 | Â | 98/286 | 26/75 | Â | 48/119 | 29/71 | Â | 19/25 | 43/57 | Â |
Reason for abandonment | ||||||||||||||
 Thrombosed AVF | 64 | 4.8 | 34 | 4.6 | 53.1 | 14 | 3.6 | 21.9 | 11 | 6.6 | 17.2 | 5.0 | 11.4 | 7.8 |
 Deceased | 352 | 26.5 | 202 | 27.6 | 57.4 | 85 | 22.1 | 24.1 | 50 | 29.9 | 14.2 | 15.0 | 34.1 | 4.3 |
 No function | 50 | 3.8 | 31 | 4.2 | 62.0 | 7 | 1.8 | 14.0 | 7 | 4.2 | 14.0 | 5.0 | 11.4 | 10.0 |
 Primary occlussion | 1 | 0.1 | 0 | 0.0 | 0.0 | 1 | 0.3 | 100.0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
 Ligated AVF | 56 | 4.2 | 36 | 4.9 | 64.3 | 10 | 2.6 | 17.9 | 7 | 4.2 | 12.5 | 3.0 | 6.8 | 5.4 |
 Patients choise | 7 | 0.5 | 7 | 1.0 | 100.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
 Lost to follow up | 5 | 0.4 | 2 | 0.3 | 40.0 | 1 | 0.3 | 20.0 | 2 | 1.2 | 40.0 | 0.0 | 0.0 | 0.0 |
 End of study | 793 | 59.7 | 421 | 57.4 | 53.1 | 266 | 69.3 | 33.5 | 90 | 53.9 | 11.3 | 16.0 | 36.4 | 2.0 |
Region in Sweden | ||||||||||||||
 North | 166 | 8.7 | 54 | 7.4 | 32.5 | 47 | 12.2 | 28.3 | 15 | 9 | 9.0 | 0 | 0 | 0.0 |
 Stockholm | 217 | 16.3 | 61 | 8.3 | 28.1 | 53 | 13.8 | 24.4 | 101 | 60.5 | 46.5 | 2 | 4.5 | 0.9 |
 Southeast | 174 | 13.1 | 98 | 13.4 | 56.3 | 71 | 18.5 | 40.8 | 1 | 0.6 | 0.6 | 4 | 9.1 | 2.3 |
 South | 312 | 23.5 | 229 | 31.2 | 73.4 | 66 | 17.2 | 21.2 | 8 | 48 | 2.6 | 9 | 20.5 | 2.9 |
 Uppsala Örebro | 253 | 19.1 | 136 | 18.6 | 53.8 | 61 | 15.9 | 24.1 | 33 | 19.8 | 13.0 | 23 | 52.3 | 9.1 |
 West | 256 | 19.3 | 155 | 21.1 | 60.5 | 86 | 22.4 | 33.6 | 9 | 5.4 | 3.5 | 6 | 13.6 | 2.3 |